Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 15 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

3 trials in Phase 3/4

Results Transparency

17%

1 of 6 completed trials have results

Key Signals

2 recruiting1 with results

Enrollment Performance

Analytics

Phase 3

3(37.5%)

N/A

3(37.5%)

Phase 1

1(12.5%)

Phase 2

1(12.5%)

8Total

Phase 3(3)

N/A(3)

Phase 1(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (15)

Showing 15 of 15 trials

NCT04010955Active Not Recruiting

Adding Antiplatelet During Edoxaban Treatment in Stroke Patients With Non-valvular Atrial Fibrillation (ADD-ON)

Role: collaborator

NCT06713252Not ApplicableRecruiting

Art Therapy and Its Effect on Non-Motor Function Rehabilitation in the Subacute Phase of Stroke Recovery

Role: lead

NCT06709950Not ApplicableRecruiting

Art Therapy and Its Effect on Motor Function Rehabilitation in the Subacute Phase of Stroke Recovery

Role: lead

NCT03597633Unknown

Tenofovir Combination or Mono-therapy for MDR CHB

Role: collaborator

NCT03049683Unknown

Simultaneous Recordings of Cervical and Ocular Vestibular-evoked Myogenic Potentials

Role: lead

NCT01822002Not ApplicableUnknown

Treatment of Posterior Canal Type of Benign Paroxysmal Positional Vertigo

Role: lead

NCT01645748Phase 2Completed

Docetaxel, Cisplatin, and S-1 (TPS) Induction Chemotherapy in Locally Advanced Head and Neck Cancer

Role: collaborator

NCT01315457Completed

Infections Associated With the Use of Alemtuzumab

Role: collaborator

NCT00810641Phase 3Completed

Treatment of Apogeotropic Horizontal Canal Benign Paroxysmal Positional Vertigo

Role: lead

NCT01366430Phase 3Completed

Treatment of Geotropic Horizontal Canal Benign Paroxysmal Positional Vertigo

Role: lead

NCT01073059Phase 1Completed

Pharmacokinetic Interactions in Combination Treatment of Valproic Acid and Ertapenem in Normal Subjects

Role: lead

NCT01211054Unknown

Epidemiologic Analysis for the Prevalence of Chronic Airway Diseases in Old Population

Role: lead

NCT01211015Unknown

Endoplasmic Reticulum Stress in Chronic Respiratory Diseases

Role: lead

NCT01037842Phase 3Completed

Effect of Combination of Mitiglinide and Metformin on Glycemic Control in Patients With Type 2 Diabetes Mellitus

Role: collaborator

NCT00849836Unknown

Novel Biomarkers in Chronic Airway Diseases

Role: lead

All 15 trials loaded